Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 23;2015(10):CD006171.
doi: 10.1002/14651858.CD006171.pub4.

Prenatal education for congenital toxoplasmosis

Simona Di Mario  1 , Vittorio Basevi, Carlo Gagliotti, Daniela Spettoli, Gianfranco Gori, Roberto D'Amico, Nicola Magrini
Affiliations

Prenatal education for congenital toxoplasmosis

Simona Di Mario et al. Cochrane Database Syst Rev. .

Abstract

Background: Congenital toxoplasmosis is considered a rare but potentially severe infection. Prenatal education about congenital toxoplasmosis could be the most efficient and least harmful intervention, yet its effectiveness is uncertain.

Objectives: To assess the effects of prenatal education for preventing congenital toxoplasmosis.

Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 May 2015), and reference lists of relevant papers, reviews and websites.

Selection criteria: Randomized and quasi-randomized controlled trials of all types of prenatal education on toxoplasmosis infection during pregnancy. Cluster-randomized trials were eligible for inclusion.

Data collection and analysis: Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy.

Main results: Two cluster-randomized controlled trials (RCTs) (involving a total of 5455 women) met the inclusion criteria. The two included trials measured the effectiveness of the intervention in different ways, which meant that meta-analysis of the results was not possible. The overall quality of the two studies, as assessed using the GRADE approach, was low, with high risk of detection and attrition bias in both included trials.One trial (432 women enrolled) conducted in Canada was judged of low methodological quality. This trial did not report on any of the review's pre-specified primary outcomes and the secondary outcomes reported results only as P values. Moreover, losses to follow-up were high (34%, 147 out of 432 women initially enrolled). The authors concluded that prenatal education can effectively change pregnant women's behavior as it increased pet, personal and food hygiene. The second trial conducted in France was also judged of low methodological quality. Losses to follow-up were also high (44.5%, 2233 out of 5023 women initially enrolled) and differential (40% in the intervention group and 52% in the control group). The authors concluded that prenatal education for congenital toxoplasmoses has a significant effect on improving women's knowledge, whereas it has no effect on changing women's behavior. In this trial 17/3949 pregnant women seroconverted for toxoplasmosis: 13/2591 (0.5%) in the intervention group and 4/1358 (0.3%) in the control group. The rate of seroconversion detected during the study did not differ between groups (risk ratio (RR) 1.70, 95% confidence interval (CI) 0.56 to 5.21; participants = 3949; studies = one, low quality evidence). The number of events was too small to reach conclusions about the effect of prenatal education on seroconversion rate during pregnancy.No other randomized trials on the effect of prenatal education on congenital toxoplasmosis rate, or toxoplasmosis seroconversion rate during pregnancy were detected.

Authors' conclusions: Even though primary prevention of congenital toxoplasmosis is considered a desirable intervention, given the lack of related risks compared to secondary and tertiary prevention, its effectiveness has not been adequately evaluated. There is very little evidence from RCTs that prenatal education is effective in reducing congenital toxoplasmosis even though evidence from observational studies suggests it is. Given the lack of good evidence supporting prenatal education for congenital toxoplasmosis prevention, further RCTs are needed to confirm any potential benefits and to further quantify the impact of different sets of educational intervention.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Brochure and an audiotape compared to standard care, Outcome 1 Rate of toxoplasmosis seroconversion during pregnancy.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Carter 1989 {published data only}
    1. Carter AO, Gelmon SB, Wells GA, Toepell AP. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiology and Infection 1989;103:539‐45. - PMC - PubMed
Wallon 2006 {published data only}
    1. Gollub EL, Leroy V, Gilbert R, Chêne G, Wallon M, the European Toxoprevention Study Group (EUROTOXO). Effectiveness of health education on Toxoplasma‐related knowledge, behaviour, and risk of seroconversion in pregnancy. European Journal of Obstetric & Gynecology and Reproductive Biology 2008;136:137‐45. - PubMed
    1. Nguyen DT. Evolution des connaissances et des comportements au cours d'un programme d'éducation prénatal pour la prévention primaire de la toxoplasmose congénitale chez les femmes enceintes séronégatif pour la toxoplasmose. Règion de Lyon, 1994‐1995 [Impact on knowledge and behaviour of a prenatal education programme to prevent congenital toxoplasmosis among seronegative pregnant women. Lyon region, 1994‐1995] [Masters thesis]. Bordeaux: University of Bordeaux, Juillet 2004.
    1. Wallon M, Nguyen Hoang Hanh DT, Peyron F, Chene G. Impact of health education for the primary prevention of toxoplasma infection in pregnancy: lessons from the ERIS study. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 2006 April 1‐4; Nice, France. 2006:Abstract no: P876.

References to studies excluded from this review

Breugelmans 2004 {published data only}
    1. Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy ‐ an epidemiologic survey over 22 consecutive years. Journal of Perinatal Medicine 2004;32:211‐4. - PubMed
    1. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. American Journal of Perinatology 1994;11:57‐62. - PubMed
    1. Foulon W, Naessens A, Lauwers S, Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstetrics & Gynaecology 1988;72:363‐6. - PubMed
Molé 1992 {published data only}
    1. Molé JR, Suárez D, Alonso F, Piquera G. This is what we did to prevent congenital toxoplasmosis in Manzanillo [Lo que hacemos para prevenir la toxoplasmosis congénita en Manzanillo]. Revista Cubana de Medicina General Integral 1992;8(4):330‐2.
Pawlowski 2001 {published data only}
    1. Pawlowski ZS, Gromadecka‐Sutkiewicz M, Skommer J, Paul M, Rokossowski H, Suchocka E, et al. Impact of health education on knowledge and prevention behavior for congenital tooplasmosis: the experience in Poznan, Poland. Health Education Research 2001;16(4):493‐502. - PubMed

Additional references

Alfirevic 2003
    1. Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003252] - DOI - PMC - PubMed
Allain 1998
    1. Allain JP, Palmer CR, Pearson G. Epidemiological study of latent and recent infection by toxoplasma gondii in pregnant women from a regional population in the UK. Journal of Infection 1998;36:189‐96. - PubMed
Bader 1997
    1. Bader TJ, Macones GA, Asch DA. Prenatal screening for toxoplasmosis. Obstetrics & Gynecology 1997;90:457‐64. - PubMed
Boyer 2005
    1. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, et al. Risk factors for toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. American Journal of Obstetrics and Gynecology 2005;192:564‐71. - PubMed
Campbell 2004
    1. Campbell MK, Elbourne DR, Altman DG for the CONSORT Group. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702‐8. - PMC - PubMed
Chabbert 2004
    1. Chabbert E, Lachaud L, Crobu L, Bastien P. Comparison of two widely used PCR primer systems for detection of toxoplasma in amniotic fluid, blood, and tissues. Clinical Microbiology 2004;42:1719‐22. - PMC - PubMed
Chamberlain 2013
    1. Chamberlain C, O’Mara‐Eves A, Oliver S, Caird JR, Perlen SM, Eades SJ, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD001055.pub4] - DOI - PMC - PubMed
Cook 2000
    1. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case‐control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142‐7. - PMC - PubMed
Dunn 1999
    1. Dunn D. Mother to child transmission of toxoplasmosis: risks estimates or clinical counselling. Lancet 1999;353:1829‐33. - PubMed
EpiInfo 6 [Computer program]
    1. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, et al. EpiInfo, Version 6: a word processing, database, and statistics programs for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
Ferguson 2011
    1. Ferguson W, Mayne PD, Cafferkey M, Butler K. Lack of awareness of risk factors for primary toxoplasmosis in pregnancy. Irish Journal of Medical Science 2011;180:807‐11. - PubMed
Foulon 1988
    1. Foulon W, Naessens A, Lauwers S, Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstetrics & Gynecology 1988;72:363‐6. - PubMed
Foulon 1994
    1. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. American Journal of Perinatology 1994;11:57‐62. - PubMed
Foulon 1999a
    1. Foulon W, Villena I, Stray‐Pederson B, Decoster A, Lappalainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children sequelae at age 1 year. American Journal of Obstetrics and Gynecology 1999;180:410‐5. - PubMed
Foulon 1999b
    1. Foulon W, Pinon JM, Stray‐Pederson B, Pollak A, Lappalainen M, Decoster A, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. American Journal of Obstetrics and Gynecology 1999;181:843‐7. - PubMed
Foulon 2000
    1. Foulon W, Naessens A, Ho‐Yen D. Prevention of congenital toxoplasmosis. Journal of Perinatal Medicine 2000;28:337‐45. - PubMed
Gilbert 1999
    1. Gilbert RE. Epidemiology of infection in pregnant women. In: Petersen E, Amboise‐Thomas P editor(s). Congenital Toxoplasmosis: Scientific Background, Clinical Management and Control. Paris: Springer‐Verlag France, 1999.
Gilbert 2001
    1. Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, Lebech M, et al. Ecological comparison of the risks of mother‐to‐child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiology and Infection 2001;127:113‐20. - PMC - PubMed
Gilbert 2002
    1. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?. Journal of Medical Screening 2002;9:135‐41. - PubMed
Gilbert 2003
    1. Gilbert R, Gras L. European multicentre study on congenital toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG: an international journal of obstetrics and gynaecology 2003;110:112‐20. - PubMed
Gilbert 2007
    1. Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. Journal of Medical Screening 2007;14:8‐13. - PubMed
Golloub 2008
    1. Gollub EL, Leroy V, Gilbert R, Chêne G, Wallon M, European ToxopreventionStudy Group (EUROTOXO). Effectiveness of health education on Toxoplasma‐relatedknowledge, behaviour, and risk of seroconversion in pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2008;136:137‐45. - PubMed
Hahn 2005
    1. Hahn S, Puffer S, Torgerson DJ, Watson J. Methodological bias in cluster randomised trials. BMC Medical Research Methodology 2005;5:10. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Lebech 1996
    1. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, et al. Classification system and case definitions of toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. European Journal of Clinical Microbiology and Infectious Diseases 1996;15:799‐805. - PubMed
Lebech 1999
    1. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Petersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 1999;353:1834‐7. - PubMed
Liesenfeld 1997
    1. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac‐Renton JL, Hedman K, et al. False‐positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia toxo IgM test. Journal of Clinical Microbiology 1997;35:174‐8. - PMC - PubMed
Montoya 2004
    1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965‐76. - PubMed
Nguyen 2004
    1. Nguyen DT. Evolution of knowledge and behavior during a prenatal education program for primary prevention of congenital toxoplasmosis in pregnant women seronegative for toxoplasmosis [Evolution des connaissances et des comportements au cours d’un programme d’éducation prénatal pour la prévention primaire de la toxoplasmose congénitale chez les femmes enceintes séronégatif pour la toxoplasmose]. Région de Lyon, 1994–1995. Juillet 2004.
NSC 2001
    1. National Screening Committee Working Group. Antenatal and Newborn Screening for Toxoplasmosis. Report of the Working Group ‐‐ October 2001. National Screening Committee, 2001.
Peyron 1999
    1. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: 10.1002/14651858.CD001684] - DOI - PMC - PubMed
Puffer 2003
    1. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ 2003;327:785‐9. - PMC - PubMed
Reis 1999
    1. Reis R, Lösch R, Lago EG. Primary prevention of congenital toxoplsmosis [Prevenção primária da toxoplasmose congênita]. Acta Médica 1999;20:704‐20.
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rorman 2006
    1. Rorman E, Stein Zamir C, Rilkis I, Ben‐David H. Congenital toxoplasmosis ‐ prenatal aspects of toxoplasma gondii infection. Reproductive Toxicology 2006;21(4):458‐72. - PubMed
Schmidt 2006
    1. Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999‐2002. Archives of Disease in Childhood 2006;91:661‐5. - PMC - PubMed
Signorell 2006
    1. Signorell LM, Seitz D, Merkel S, Berger R, Rudin C. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982‐1999. Pediatric Infectious Disease Journal 2006;25:123‐8. - PubMed
SYROCOT 2007
    1. Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta‐analysis of individual patients' data. Lancet 2007;369:115‐22. - PubMed
Thalib 2005
    1. Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG: an international journal of obstetrics and gynaecology 2005;112:567‐74. - PubMed
Torgerson 2001
    1. Torgerson DJ. Contamination in trials: is cluster randomisation the answer?. BMJ 2001;322:355‐7. - PMC - PubMed
Wilson 1980
    1. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66:767‐74. - PubMed

References to other published versions of this review

Di Mario 2006
    1. Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, et al. Prenatal education for congenital toxoplasmosis. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD006171] - DOI
Di Mario 2009
    1. Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, et al. Prenatal education for congenital toxoplasmosis. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006171.pub2] - DOI - PubMed
Di Mario 2013
    1. Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, Magrini N. Prenatal education for congenital toxoplasmosis. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD006171.pub3] - DOI - PubMed

Publication types

MeSH terms